2017 Press Releases

2017 Press Releases

2017 | 2016 | 2015
  • Jan 19, 2017 

    Novavax Initiates Phase 2 Safety and Immunogenicity Trial of the RSV F Vaccine in Older Adults - 

    GAITHERSBURG, Md., Jan. 19, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced the initiation of a Phase 2 clinical trial of its respiratory syncytial virus F-protein nanoparticle vaccine candidate (RSV F Vaccine) in older adults (60 years of age and older). The objective of the trial is to assess safety and immunogenicity to one and two dose regimens of the RSV F Vaccine, with and without aluminum phosphate or Novavax’ proprietary Matrix-M™ adjuvant, in older adults. The ... More >>

  • Jan 05, 2017 

    Novavax to Present at the 35th Annual J.P. Morgan Healthcare Conference - 

    GAITHERSBURG, Md., Jan. 05, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that management will present at the 35th Annual J.P. Morgan Healthcare Conference. Presentation details are as follows: Date: Thursday, January 12, 2017 Time: 9:30 am U.S. Pacific Time Location: California East room, Westin St. Francis Hotel, San Francisco Live webcast: novavax.com, “Investors”/ “Events” The webcast and replay of the presentation will also be accessible under the “Investors... More >>